Combination immune checkpoint inhibitors with platinum-based chemotherapy in advanced non-small cell lung cancer: what’s known and what’s next

類似資料

• Shining light on advanced NSCLC in 2017: combining immune checkpoint inhibitors
  著者:: Qiao, Meng, 等
  出版事項: (2018)
• Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer
  著者:: Zhou, Fei, 等
  出版事項: (2020)
• Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
  著者:: Ferrara, Roberto, 等
  出版事項: (2021)
• Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
  著者:: Ferrara, Roberto, 等
  出版事項: (2020)
• Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer
  著者:: Kuo, Chih‐Hsi Scott, 等
  出版事項: (2019)